AzTrials
AzTrials

Carotid ArteryPRIMENCT07877480

Predicting High-Risk Carotid Plaque: Integrating radioMics and biomEchanics

A study testing Radiomic features analysis in people with Carotid Artery and Carotid Arteriosclerosis, run by Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico at 1 site in Italy.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record

Search all trials

Trial summary

Non-pharmacological interventional study for the development of a predictive model aimed at identifying unstable carotid plaques in asymptomatic patients at first diagnosis, with the use of biological material and prospective-retrospective data collection Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Carotid Artery, Carotid Arteriosclerosis
What is being tested?
Radiomic features analysis
Could I receive a placebo?
No, everyone receives an active treatment
How many people
420 participants
Where
1 siteItaly
Study dates
1 Sep 2025to 30 Dec 2026
Phase
Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients ≥ 18 years of age;
  • Affected by significant carotid atherosclerosis, whether symptomatic or asymptomatic (stenosis ≥ 70% according to ECST criteria).
  • Candidates for carotid ATE surgery. The criteria provided by the SICVE and ESVS guidelines will be followed for indications for surgery;
  • Preoperative imaging available;

Who cannot join

  • Patients who have undergone previous carotid endarterectomy (ipsilateral to the affected side);
  • Patients who have undergone previous neck surgery involving cervical lymph node dissection;
  • Patients who have undergone previous neck radiation therapy;
  • Lack of preoperative imaging;
  • Patients unable to sign informed consent.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Italy1 site, 1 recruiting
  • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

    Milan

    MAURIZIO DOMANIN, MD, +390255032438, maurizio.domanin@unimi.it

    Recruiting

Other trials in Italy

About this study

Non-pharmacological interventional study for the development of a predictive model aimed at identifying unstable carotid plaques in asymptomatic patients at first diagnosis, with the use of biological material and prospective-retrospective data collection

Read the detailed description

Stroke is a leading cause of mortality and morbidity globally, accounting for 12 million cases worldwide in 2019 and a global cost of $891 billion in 2017. One of the main causes of stroke is the rupture of atheromatous plaque in the carotid artery. For this reason, identifying and studying plaques is essential to preventing stroke and cerebrovascular events.

European guidelines recommend risk stratification strategies for carotid plaques based on the degree of stenosis they cause and the assessment, through radiological imaging, of their core characteristics. However, this stratification alone is still not enough. In recent years, scientific research has succeeded in identifying additional markers of instability in the morphological and compositional characteristics of plaques based on imagery.

Finally, radiomics, a new field of high-throughput extraction of quantitative features observable in radiological images, has demonstrated promising results in recognizing and stratifying unstable carotid plaques.

The overall aim of the study is to create a predictive model that aims to identify unstable plaques in asymptomatic patients at initial diagnosis. Currently, the most effective objective method for assessing plaque instability is histopathological analysis, but this is only available after surgery. Therefore, it is crucial to have a noninvasive predictive model for identifying the risk of cerebrovascular accidents in asymptomatic patients.

Specifically, the primary objective is to identify carotid plaque instability by extracting radiomic markers belonging to the "shape and size" (26 shape and size features), "first-order statistics" (19 statistical features), and "textural" (75 texture features) classes from each CTA image. A further objective will be the calculation of mechanical markers (von Mises stress, maximum principal stress, ultimate stress, and thickness) capable of identifying carotid plaque instability in patients with carotid stenosis and candidates for carotid artery stenosis surgical removal.

The study will involve patients attending the Foundation's Vascular Surgery Unit and candidates for carotid artery stenosis. Two specific phases are planned. The first phase will be retrospective and will involve the retrieval of clinical and imaging data to activate machine learning for the analysis of radiomics data in combination with clinical data. Preoperative CT images and perioperative clinical data will be analyzed for training and preliminary development of a machine learning model based on radiomics, clinical, and biomechanical data, calculated from structural and fluid dynamics numerical simulations. Patient-specific preoperative CT images will be segmented using 2D convolutional neural networks (CNNs). The resulting 3D models of vessels and plaques will be used for structural and fluid dynamic simulations and radiomics analysis.

In the second prospective phase, patients will be enrolled consecutively, according to the SOC's indication for surgery. After obtaining written informed consent, the inclusion/exclusion criteria will be evaluated and each patient will be assigned a progressive identification code. Preoperative clinical and imaging (CT) data will be collected. The prospectively enrolled patients will undergo the same procedure (carotid TEA), according to the protocols and standards proposed by the European Society of Vascular Surgery (ESVS) and adopted in common clinical practice by our SC.

At the end of the TEA procedure, in addition to collecting pre- and post-operative clinical data, histopathological and biomechanical analysis of the surgically removed plaque, which is usually not analyzed and disposed of, will be performed. The results will be used to prepare and validate the virtual predictive model. The surgeon will send the removed material, in alternating sequence, once for histology and once for mechanical testing. Subsequently, numerical strategies will be adopted to calculate the biomechanics of carotid arteries affected by the presence of plaque. In addition to these numerical approaches, a machine learning algorithm will be used to couple the previously identified variables (i.e., morphological, histological, radiomic, and biomechanical) to identify markers capable of identifying unstable plaques.

Finally, 3D printing will be used to produce anatomical and functional models of the segmented geometries of patients undergoing TEA. These prints will be inserted into a hydraulic circuit capable of reproducing physiopathological flow and pressure conditions. This strategy will be used to validate the results from the structural and fluid dynamic simulations in a fully controlled environment in terms of postoperative geometric conformation (postoperative diameters achieved by the anatomy) and flow distribution at the fluid dynamic level.

Being tested
Radiomic features analysis
Keywords
carotid endarterectomy, Carotid Artery Disease
Medical subject headings
Carotid Artery Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Radiomic features analysisDiagnostic test

    Identification of carotid plaque instability by extracting radiomic markers belonging to the "shape and size" (26 shape and size features), "first order statistics" (19 statistical features) and "textural" (75 texture features) classes from each CTA image

Study groups in NCT07877480
Study groupRoleWhat they receive
Radiomic AnalysisOtherNot described
Receives: Diagnostic Test: Radiomic features analysis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Radiomic markers

    Identification form CT scan images of a radiomic marker predictive of plaque instability, with an AUC ≥ 0.85.

    Measured: at enrollment

Secondary outcomes (1)
  1. Plaque mechanical markers

    Measurement of the Von Mises stress absorbed by the plate in MPa

    Measured: 24 hours post-op

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Oct 2026
  2. Study start1 Sep 2025
  3. Primary completion30 Sep 2026
  4. Study completion30 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
420 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07877480
Sponsor's protocol ID
6266
Acronym
PRIME
Status last verified
Oct 2026
First submitted
2 Oct 2026
Last updated
16 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in